Digital devices useful in visual rehabilitation

Article

Digital devices may be used as a visual rehabilitation technique for low-vision AMD patients, according to a paper featured in the journal Eye.

Digital devices may be used as a visual rehabilitation technique for low-vision AMD patients, according to a paper featured in the journal Eye.

An investigation led by Dr K. Gill, Department of Ophthalmology, University of Western Ontario, London, Ontario, Canada, included 27 patients in the study. All patients had stable wet AMD in one or both eyes and were assessed for reading speeds on both digital readers and standard paper text.

The reading speed was calculated as words per minute and each patient completed the visual analogue scale after reading each passage. The patients read font sizes ranged from newsprint to large print books and then read from digital devices for comparison.

In conclusion, patients read faster on the Apple iPad with text sizes of 24 or more, compared to paper. Patients claimed the digital device has the best clarity but the print paper is the easiest to use.

Devices with larger display screens and high contrast ratios are beneficial to AMD patients who require larger texts for reading.

The abstract can be found here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.